Creative Medical Technology (CELZ) Competitors $2.72 -0.05 (-1.81%) Closing price 03:59 PM EasternExtended Trading$2.78 +0.05 (+2.02%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. GBIO, ENLV, SCYX, NNVC, QTTB, RANI, FBLG, NRSN, CLSD, and CLDIShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Generation Bio (GBIO), Enlivex Therapeutics (ENLV), SCYNEXIS (SCYX), NanoViricides (NNVC), Q32 Bio (QTTB), Rani Therapeutics (RANI), FibroBiologics (FBLG), NeuroSense Therapeutics (NRSN), Clearside Biomedical (CLSD), and Calidi Biotherapeutics (CLDI). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors Generation Bio Enlivex Therapeutics SCYNEXIS NanoViricides Q32 Bio Rani Therapeutics FibroBiologics NeuroSense Therapeutics Clearside Biomedical Calidi Biotherapeutics Creative Medical Technology (NASDAQ:CELZ) and Generation Bio (NASDAQ:GBIO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment. Do analysts prefer CELZ or GBIO? Generation Bio has a consensus target price of $80.00, suggesting a potential upside of 1,804.76%. Given Generation Bio's stronger consensus rating and higher possible upside, analysts clearly believe Generation Bio is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Generation Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer CELZ or GBIO? In the previous week, Generation Bio had 6 more articles in the media than Creative Medical Technology. MarketBeat recorded 7 mentions for Generation Bio and 1 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 0.49 beat Generation Bio's score of -0.33 indicating that Creative Medical Technology is being referred to more favorably in the media. Company Overall Sentiment Creative Medical Technology Neutral Generation Bio Neutral Do institutionals and insiders hold more shares of CELZ or GBIO? 1.4% of Creative Medical Technology shares are owned by institutional investors. Comparatively, 95.2% of Generation Bio shares are owned by institutional investors. 2.8% of Creative Medical Technology shares are owned by company insiders. Comparatively, 21.8% of Generation Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, CELZ or GBIO? Creative Medical Technology has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500. Comparatively, Generation Bio has a beta of 2.59, suggesting that its share price is 159% more volatile than the S&P 500. Is CELZ or GBIO more profitable? Creative Medical Technology has a net margin of 0.00% compared to Generation Bio's net margin of -292.92%. Generation Bio's return on equity of -75.84% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -85.26% -81.49% Generation Bio -292.92%-75.84%-30.40% Which has higher valuation and earnings, CELZ or GBIO? Creative Medical Technology has higher earnings, but lower revenue than Generation Bio. Generation Bio is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$10K704.48-$5.49M-$3.81-0.71Generation Bio$19.89M1.41-$131.67M-$1.08-3.89 SummaryGeneration Bio beats Creative Medical Technology on 12 of the 16 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.16M$3.06B$5.70B$9.48BDividend YieldN/A2.37%4.59%3.99%P/E Ratio-0.7120.7327.9019.95Price / Sales704.48321.12442.19102.72Price / CashN/A43.2336.5558.97Price / Book0.758.308.635.90Net Income-$5.49M-$55.19M$3.24B$258.42M7 Day Performance3.82%5.07%3.22%1.94%1 Month Performance4.62%17.61%10.72%12.02%1 Year Performance-23.38%7.03%34.94%20.81% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.9019 of 5 stars$2.72-1.8%N/A-22.2%$7.16M$10K-0.715GBIOGeneration Bio3.8423 of 5 stars$4.27+1.4%$80.00+1,773.5%-86.3%$28.22M$24.56M-3.95150Stock SplitHigh Trading VolumeENLVEnlivex Therapeutics2.3119 of 5 stars$1.18-0.8%$10.00+747.5%-18.8%$28.15MN/A-1.7970News CoverageAnalyst ForecastSCYXSCYNEXIS0.2727 of 5 stars$0.71-0.2%N/A-66.9%$27.76M$3.75M-1.2760NNVCNanoViricides0.4481 of 5 stars$1.70+0.6%N/A-25.2%$27.32MN/A-2.3620Positive NewsQTTBQ32 Bio2.2478 of 5 stars$2.24+2.8%$12.17+443.2%-92.8%$26.59M$1.16M-0.4539RANIRani Therapeutics1.802 of 5 stars$0.44+4.8%$7.33+1,566.7%-85.0%$26.55M$1.03M-0.44110Gap DownFBLGFibroBiologics3.2374 of 5 stars$0.67+0.4%$13.00+1,840.0%-86.5%$26.48MN/A-3.1910NRSNNeuroSense Therapeutics2.1449 of 5 stars$1.93-0.1%$14.00+626.1%+162.5%$26.38MN/A-3.5710CLSDClearside Biomedical2.1423 of 5 stars$0.35+3.7%$4.20+1,095.2%-49.1%$26.34M$1.66M-0.8630Gap DownHigh Trading VolumeCLDICalidi Biotherapeutics0.6872 of 5 stars$0.70-2.4%N/A-56.5%$25.91MN/A0.0038Gap Up Related Companies and Tools Related Companies Generation Bio Alternatives Enlivex Therapeutics Alternatives SCYNEXIS Alternatives NanoViricides Alternatives Q32 Bio Alternatives Rani Therapeutics Alternatives FibroBiologics Alternatives NeuroSense Therapeutics Alternatives Clearside Biomedical Alternatives Calidi Biotherapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
